{"transactions":[{"id":1458373,"issuer":{"id":89130,"kind":"organization","name":"Akili, Inc.","symbol":"AKLI"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-07-08T19:42:32.000Z","date":"2024-07-02","kind":"other","planned":false,"acquired":false,"shares":12527477,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of shares of common stock (each, a \"Share\") of the Issuer at a price per Share of $0.4340 (the \"Offer Price\") pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of May 29, 2024, by and among the Issuer, Virtual Therapeutics Corporation, a Delaware corporation (\"Parent\"), and Alpha Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (\"Purchaser\"). Purchaser completed a tender offer for shares of common stock of the Issuer and thereafter merged with and into the Issuer, effective as of July 2, 2024 (the \"Effective Time\"), with the Issuer surviving the merger. As of the Effective Time, each Share held by the Reporting Person was converted into the Offer Price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"PureTech Health LLC is the record holder of all of the securities reported in this Form 4. PureTech Health plc is the sole member of PureTech Health LLC, and has the power to direct the voting and disposition of securities held by PureTech Health LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-082232","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1850266/000095017024082232/ownership.xml","form_type":"4"}},{"id":1775464,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2023-09-21T16:30:07.000Z","date":"2023-09-20","kind":"purchase","planned":false,"acquired":true,"price":1500000,"reported_value":1500000,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"derivative":{"exercise_price":0.0494,"exercise_date":"2023-09-20","expiration_date":"2024-03-31","underlying":"Common Stock","underlying_shares":30364372},"source":{"system":"sec-edgar","filing":"0000950170-23-049198","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000095017023049198/ownership.xml","form_type":"4"}},{"id":1855988,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2023-06-14T16:30:15.000Z","date":"2023-06-12","kind":"purchase","planned":false,"acquired":true,"price":3000000,"reported_value":3000000,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"derivative":{"exercise_price":0.0134,"exercise_date":"2023-06-12","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":223880597},"source":{"system":"sec-edgar","filing":"0000899243-23-015533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323015533/doc4.xml","form_type":"4"}},{"id":1873403,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-05-31T17:30:09.000Z","date":"2023-05-26","kind":"purchase","planned":false,"acquired":true,"shares":43133803,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The warrants were issued in connection with the purchase of the convertible note purchases reported herein."}],"balance_after":43133803,"derivative":{"exercise_price":0.0142,"exercise_date":"2023-05-26","expiration_date":"2028-05-26","underlying":"Common Stock","underlying_shares":43133803},"source":{"system":"sec-edgar","filing":"0000899243-23-014169","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323014169/doc4.xml","form_type":"4"}},{"id":1873402,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2023-05-31T17:30:09.000Z","date":"2023-05-26","kind":"purchase","planned":false,"acquired":true,"price":350000,"reported_value":350000,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"derivative":{"exercise_price":0.0142,"exercise_date":"2023-05-26","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":24647887},"source":{"system":"sec-edgar","filing":"0000899243-23-014169","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323014169/doc4.xml","form_type":"4"}},{"id":1906263,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-05-03T16:30:31.000Z","date":"2023-05-01","kind":"purchase","planned":false,"acquired":true,"shares":192307692,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The warrants were issued in connection with the purchase of the convertible note purchases reported herein"}],"balance_after":192307692,"derivative":{"exercise_price":0.0182,"exercise_date":"2023-05-01","expiration_date":"2028-05-01","underlying":"Common Stock","underlying_shares":192307692},"source":{"system":"sec-edgar","filing":"0000899243-23-012087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323012087/doc4.xml","form_type":"4"}},{"id":1906262,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants","published_at":"2023-05-03T16:30:31.000Z","date":"2023-05-01","kind":"purchase","planned":false,"acquired":true,"shares":23688047,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to a Note and Warrant Purchase Agreement, on February 21, 2023, the Issuer issued to PureTechHealth LLC convertible notes in an aggregate principal amount of $5,000,000 as well as warrants to purchase 23,688,047 shares of common stock. At the time of issuance, both the conversion of the convertible notes and exercise of the warrants was subject to the Issuer first receiving stockholder approval for the issuance of the underlying shares of common stock. On May 1, 2023, the Issuer and the Reporting Persons amended the terms of the convertible notes and warrants to remove this restriction on conversion and exercise, respectively."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The warrants were issued in connection with the purchase of the convertible note purchases reported herein"}],"balance_after":23688047,"derivative":{"exercise_price":0.2744,"exercise_date":"2023-05-01","expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":23688047},"source":{"system":"sec-edgar","filing":"0000899243-23-012087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323012087/doc4.xml","form_type":"4"}},{"id":1906261,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2023-05-03T16:30:31.000Z","date":"2023-05-01","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":2000000,"value":4000000000000.0,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"footnotes":[{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of shares underlying the convertible notes reported herein is based on the outstanding principal amount plus accrued and unpaid interest as of April 30, 2023, and such number is subject to adjustment in accordance with the terms of the convertible notes."}],"balance_after":2000000,"derivative":{"exercise_price":0.0182,"exercise_date":"2023-05-01","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":109890110},"source":{"system":"sec-edgar","filing":"0000899243-23-012087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323012087/doc4.xml","form_type":"4"}},{"id":1906260,"issuer":{"id":109516,"kind":"organization","name":"GELESIS HOLDINGS, INC.","symbol":"GLSH"},"owners":[{"id":9539,"kind":"organization","name":"PureTech Health plc","position":1,"cik":"0001782999","reported_name":"PureTech Health plc","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":2,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Note","published_at":"2023-05-03T16:30:31.000Z","date":"2023-05-01","kind":"purchase","planned":false,"acquired":true,"shares":5000000,"price":5000000,"value":25000000000000.0,"ownership":{"direct":false,"nature":"By PureTech Health LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to a Note and Warrant Purchase Agreement, on February 21, 2023, the Issuer issued to PureTechHealth LLC convertible notes in an aggregate principal amount of $5,000,000 as well as warrants to purchase 23,688,047 shares of common stock. At the time of issuance, both the conversion of the convertible notes and exercise of the warrants was subject to the Issuer first receiving stockholder approval for the issuance of the underlying shares of common stock. On May 1, 2023, the Issuer and the Reporting Persons amended the terms of the convertible notes and warrants to remove this restriction on conversion and exercise, respectively."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The number of shares underlying the convertible notes reported herein is based on the outstanding principal amount plus accrued and unpaid interest as of April 30, 2023, and such number is subject to adjustment in accordance with the terms of the convertible notes."}],"balance_after":5000000,"derivative":{"exercise_price":0.2744,"exercise_date":"2023-05-01","expiration_date":"2023-07-31","underlying":"Common Stock","underlying_shares":18634597},"source":{"system":"sec-edgar","filing":"0000899243-23-012087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805087/000089924323012087/doc4.xml","form_type":"4"}},{"id":2868393,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former 10% Owner"}}],"security":"Common Stock","published_at":"2021-02-10T06:14:42.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":1000000,"price":118,"value":118000000.0,"ownership":{"direct":true},"balance_after":2406564,"source":{"system":"sec-edgar","filing":"0000899243-21-005568","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727395/000089924321005568/doc4.xml","form_type":"4"}},{"id":3046022,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-26T17:15:19.000Z","date":"2020-08-26","kind":"sale","acquired":false,"shares":1333333,"price":76.2122,"value":101616241.2626,"ownership":{"direct":true},"balance_after":3406564,"source":{"system":"sec-edgar","filing":"0000899243-20-023459","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727395/000089924320023459/doc4.xml","form_type":"4"}},{"id":3134626,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T06:05:19.000Z","date":"2020-05-22","kind":"sale","acquired":false,"shares":5500,"price":84.5,"value":464750.0,"ownership":{"direct":true},"balance_after":4739897,"source":{"system":"sec-edgar","filing":"0000899243-20-014094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727395/000089924320014094/doc4.xml","form_type":"4"}},{"id":3134625,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-26T06:05:19.000Z","date":"2020-05-22","kind":"sale","acquired":false,"shares":550000,"price":81,"value":44550000.0,"ownership":{"direct":true},"balance_after":4745397,"source":{"system":"sec-edgar","filing":"0000899243-20-014094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727395/000089924320014094/doc4.xml","form_type":"4"}},{"id":3302381,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-24T16:40:43.000Z","date":"2020-01-22","kind":"sale","acquired":false,"shares":2100000,"price":95.67,"value":200907000.0,"ownership":{"direct":true},"balance_after":5295397,"source":{"system":"sec-edgar","filing":"0000899243-20-001979","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727395/000089924320001979/doc4.xml","form_type":"4"}},{"id":3335212,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-19T22:26:14.000Z","date":"2019-12-18","kind":"sale","acquired":false,"shares":6161531,"price":1.2,"value":7393837.2,"ownership":{"direct":true},"balance_after":2119696,"source":{"system":"sec-edgar","filing":"0000899243-19-029671","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924319029671/doc4.xml","form_type":"4"}},{"id":3339186,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-17T23:27:21.000Z","date":"2019-12-13","kind":"sale","acquired":false,"shares":205763,"price":1.2432,"value":255804.5616,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.24 to $1.25, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8281227,"source":{"system":"sec-edgar","filing":"0000899243-19-029467","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924319029467/doc4.xml","form_type":"4"}},{"id":3343776,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T22:59:07.000Z","date":"2019-12-12","kind":"sale","acquired":false,"shares":385884,"price":1.2499,"value":482316.4116,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.24 to $1.265, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8486990,"source":{"system":"sec-edgar","filing":"0000899243-19-029074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924319029074/doc4.xml","form_type":"4"}},{"id":3343775,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T22:59:07.000Z","date":"2019-12-11","kind":"sale","acquired":false,"shares":59921,"price":1.25,"value":74901.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.25 to $1.255, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8872874,"source":{"system":"sec-edgar","filing":"0000899243-19-029074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924319029074/doc4.xml","form_type":"4"}},{"id":3343774,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-12T22:59:07.000Z","date":"2019-12-10","kind":"sale","acquired":false,"shares":336561,"price":1.2588,"value":423662.9868,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.25 to $1.29, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":8932795,"source":{"system":"sec-edgar","filing":"0000899243-19-029074","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924319029074/doc4.xml","form_type":"4"}},{"id":3366116,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-11-19T21:25:38.000Z","date":"2019-11-15","kind":"sale","acquired":false,"shares":531040,"price":1.2465,"value":661941.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 to $1.43, inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":9269356,"source":{"system":"sec-edgar","filing":"0000899243-19-027581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924319027581/doc4.xml","form_type":"4"}},{"id":3470267,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-07-02T17:15:02.000Z","date":"2019-07-02","kind":"exercise","acquired":false,"shares":330250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series B Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock. The Series B Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series B Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock. The Series B Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series B Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock. The Series B Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series B Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock. The Series B Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":428895},"source":{"system":"sec-edgar","filing":"0000899243-19-018912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1727395/000089924319018912/doc4.xml","form_type":"4"}},{"id":3470266,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2019-07-02T17:15:02.000Z","date":"2019-07-02","kind":"exercise","acquired":false,"shares":1348814,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock. The Series A Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock. The Series A Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series A Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock. The Series A Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock. The Series A Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1751704},"source":{"system":"sec-edgar","filing":"0000899243-19-018912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1727395/000089924319018912/doc4.xml","form_type":"4"}},{"id":3470265,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series Seed Preferred Stock","published_at":"2019-07-02T17:15:02.000Z","date":"2019-07-02","kind":"exercise","acquired":false,"shares":4000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series Seed Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series Seed Preferred Stock automatically converted into shares of Common Stock. The Series Seed Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series Seed Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series Seed Preferred Stock automatically converted into shares of Common Stock. The Series Seed Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series Seed Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series Seed Preferred Stock automatically converted into shares of Common Stock. The Series Seed Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series Seed Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series Seed Preferred Stock automatically converted into shares of Common Stock. The Series Seed Preferred Stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5194800},"source":{"system":"sec-edgar","filing":"0000899243-19-018912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1727395/000089924319018912/doc4.xml","form_type":"4"}},{"id":3470264,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T17:15:02.000Z","date":"2019-07-02","kind":"exercise","acquired":true,"shares":428895,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series B Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock. The Series B Preferred Stock has no expiration date."}],"balance_after":7395397,"source":{"system":"sec-edgar","filing":"0000899243-19-018912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1727395/000089924319018912/doc4.xml","form_type":"4"}},{"id":3470263,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T17:15:02.000Z","date":"2019-07-02","kind":"exercise","acquired":true,"shares":1751704,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series A Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series A Preferred Stock automatically converted into shares of Common Stock. The Series A Preferred Stock has no expiration date."}],"balance_after":6966502,"source":{"system":"sec-edgar","filing":"0000899243-19-018912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1727395/000089924319018912/doc4.xml","form_type":"4"}},{"id":3470262,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-02T17:15:02.000Z","date":"2019-07-02","kind":"exercise","acquired":true,"shares":5194800,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series Seed Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series Seed Preferred Stock automatically converted into shares of Common Stock. The Series Seed Preferred Stock has no expiration date."}],"balance_after":5214798,"source":{"system":"sec-edgar","filing":"0000899243-19-018912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1727395/000089924319018912/doc4.xml","form_type":"4"}},{"id":4084976,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-01-30T23:37:14.000Z","date":"2018-01-30","kind":"exercise","acquired":false,"shares":7680700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1.2804-for-1 basis on January 30, 2018 and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1.2804-for-1 basis on January 30, 2018 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1.2804-for-1 basis on January 30, 2018 and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 1.2804-for-1 basis on January 30, 2018 and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7680700},"source":{"system":"sec-edgar","filing":"0000899243-18-002313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924318002313/doc4.xml","form_type":"4"}},{"id":4084975,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-30T23:37:14.000Z","date":"2018-01-30","kind":"purchase","acquired":true,"shares":233333,"price":15,"value":3499995.0,"ownership":{"direct":true},"balance_after":9800396,"source":{"system":"sec-edgar","filing":"0000899243-18-002313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924318002313/doc4.xml","form_type":"4"}},{"id":4084974,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":89131,"kind":"organization","name":"PureTech Health LLC","position":1,"cik":"0001727395","reported_name":"PureTech Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-30T23:37:14.000Z","date":"2018-01-30","kind":"exercise","acquired":true,"shares":7680700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the total number of shares of Common Stock received by the Reporting Person upon conversion of the Issuer's Series A Preferred Stock in connection with the closing of the Issuer's initial public offering."}],"balance_after":9567063,"source":{"system":"sec-edgar","filing":"0000899243-18-002313","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720580/000089924318002313/doc4.xml","form_type":"4"}}]}